Erika Gebel Berg

2.2k total citations
41 papers, 1.6k citations indexed

About

Erika Gebel Berg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Erika Gebel Berg has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Immunology. Recurrent topics in Erika Gebel Berg's work include Immune Cell Function and Interaction (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Diabetes Management and Research (4 papers). Erika Gebel Berg is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Diabetes Management and Research (4 papers). Erika Gebel Berg collaborates with scholars based in Germany, United States and Netherlands. Erika Gebel Berg's co-authors include Christoph Loddenkemper, Rainer Duchmann, Martin Zeitz, Jochen Maul, Andreas Stallmach, Pamela Mundt, Thomas Giese, Harald Stein, Sabine Voigt and Eckhard Thiel and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Erika Gebel Berg

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Gebel Berg Germany 14 684 334 329 325 207 41 1.6k
James B. Breitmeyer United States 23 653 1.0× 171 0.5× 609 1.9× 412 1.3× 167 0.8× 60 2.1k
Pietro Di Lucia Italy 18 1.2k 1.8× 175 0.5× 338 1.0× 497 1.5× 101 0.5× 25 2.7k
Adam M. Zawada Germany 23 1.0k 1.5× 93 0.3× 558 1.7× 294 0.9× 97 0.5× 52 2.3k
In‐Ho Song United States 28 1.0k 1.5× 197 0.6× 228 0.7× 214 0.7× 62 0.3× 84 2.7k
Kendra A. Young United States 23 488 0.7× 138 0.4× 385 1.2× 160 0.5× 106 0.5× 63 1.7k
Long Shen China 25 218 0.3× 213 0.6× 295 0.9× 118 0.4× 174 0.8× 79 1.6k
Steven E. Carsons United States 27 908 1.3× 123 0.4× 486 1.5× 342 1.1× 62 0.3× 92 2.6k
Rachel H. McMahan United States 22 872 1.3× 79 0.2× 474 1.4× 402 1.2× 73 0.4× 57 1.7k
Omar Qureshi United Kingdom 13 1.8k 2.6× 268 0.8× 292 0.9× 890 2.7× 85 0.4× 24 2.7k
Andrea Finocchi Italy 24 886 1.3× 286 0.9× 505 1.5× 123 0.4× 42 0.2× 84 1.8k

Countries citing papers authored by Erika Gebel Berg

Since Specialization
Citations

This map shows the geographic impact of Erika Gebel Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Gebel Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Gebel Berg more than expected).

Fields of papers citing papers by Erika Gebel Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Gebel Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Gebel Berg. The network helps show where Erika Gebel Berg may publish in the future.

Co-authorship network of co-authors of Erika Gebel Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Gebel Berg. A scholar is included among the top collaborators of Erika Gebel Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Gebel Berg. Erika Gebel Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Treese, Christoph, Mathias Dahlmann, Moritz von Winterfeld, et al.. (2022). S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus. Cells. 11(6). 1056–1056. 6 indexed citations
2.
Treese, Christoph, Moritz von Winterfeld, Erika Gebel Berg, et al.. (2022). Inhibition of MACC1-Induced Metastasis in Esophageal and Gastric Adenocarcinomas. Cancers. 14(7). 1773–1773. 8 indexed citations
3.
Jovanović, Vladimir, Annika Lehmann, Hedwig Lammert, et al.. (2022). Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies. Journal of Cancer Research and Clinical Oncology. 149(3). 1049–1061. 3 indexed citations
4.
Staudacher, Jonas J., Alexander Arnold, Anja A. Kühl, et al.. (2022). Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas. BMC Cancer. 22(1). 953–953. 5 indexed citations
5.
Berg, Erika Gebel, Michael Hummel, Ulrike Stein, et al.. (2020). Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression. OncoImmunology. 9(1). 1824632–1824632. 15 indexed citations
6.
Arnold, Alexander, S Daum, Moritz von Winterfeld, et al.. (2020). Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas. Clinical & Translational Oncology. 22(12). 2357–2363. 57 indexed citations
7.
Dimitrova, Lora, Erika Gebel Berg, Franziska Taruttis, et al.. (2019). Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma. BMC Cancer. 19(1). 322–322. 10 indexed citations
8.
Briest, Franziska, Yawen Wang, Ruža Arsenić, et al.. (2018). Immunohistochemical Study of Mitosis-regulatory Proteins in Gastroenteropancreatic Neuroendocrine Neoplasms. Anticancer Research. 38(7). 3863–3870. 6 indexed citations
9.
Berg, Erika Gebel. (2016). Designer Drug Detective Work. ACS Central Science. 2(6). 363–366. 5 indexed citations
10.
Treese, Christoph, P. Sánchez, Patricia Grabowski, et al.. (2016). Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas. PLoS ONE. 11(12). e0168237–e0168237. 2 indexed citations
11.
Nadeau, Kristen J., Barbara J. Anderson, Erika Gebel Berg, et al.. (2016). Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities. Diabetes Care. 39(9). 1635–1642. 262 indexed citations
12.
Leibel, Rudolph L., Randy J. Seeley, Tamara Darsow, et al.. (2015). Biologic Responses to Weight Loss and Weight Regain: Report From an American Diabetes Association Research Symposium. Diabetes. 64(7). 2299–2309. 38 indexed citations
13.
Berg, Erika Gebel. (2015). Breaking the Crystal Ceiling. ACS Central Science. 1(6). 283–285. 1 indexed citations
14.
Seitz, Volkhard, Karin Zimmermann, Erika Gebel Berg, et al.. (2012). Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype. Haematologica. 98(2). 247–254. 10 indexed citations
15.
Hadler‐Olsen, Elin, Jan‐Olof Winberg, Finn P. Reinholt, et al.. (2011). Proteases in Plasma and Kidney of db/db Mice as Markers of Diabetes-Induced Nephropathy. PubMed. 2011. 1–10. 9 indexed citations
16.
Epple, Hans–Jörg, Christoph Loddenkemper, Désirée Kunkel, et al.. (2006). Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood. 108(9). 3072–3078. 165 indexed citations
17.
Rieger, Kathrin, Christoph Loddenkemper, Jochen Maul, et al.. (2005). Mucosal Foxp3 + Regulatory T Cells Show Significant Numerical Differences in Patients with Intestinal Graft-Versus-Host Disease Compared to Infectious Diseases of the Gut.. Blood. 106(11). 596–596. 1 indexed citations
18.
Maul, Jochen, Christoph Loddenkemper, Pamela Mundt, et al.. (2005). Peripheral and Intestinal Regulatory CD4+CD25high T Cells in Inflammatory Bowel Disease. Gastroenterology. 128(7). 1868–1878. 488 indexed citations
19.
Foss, Hans‐Dieter, Hermann Herbst, Iguaracyra Araújo, et al.. (1996). MONOKINE EXPRESSION IN LANGERHANS' CELL HISTIOCYTOSIS AND SINUS HISTIOCYTOSIS WITH MASSIVE LYMPHADENOPATHY (ROSAI–DORFMAN DISEASE). The Journal of Pathology. 179(1). 60–65. 5 indexed citations
20.
Herbst, Hermann, Iguaracyra Araújo, Michael Hummel, et al.. (1996). MONOKINE EXPRESSION IN LANGERHANS' CELL HISTIOCYTOSIS AND SINUS HISTIOCYTOSIS WITH MASSIVE LYMPHADENOPATHY (ROSAI-DORFMAN DISEASE). The Journal of Pathology. 179(1). 60–65. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James B. Breitmeyer Breakdown of academic impact, for papers by Pietro Di Lucia Breakdown of academic impact, for papers by Adam M. Zawada Breakdown of academic impact, for papers by In‐Ho Song Breakdown of academic impact, for papers by Kendra A. Young Breakdown of academic impact, for papers by Long Shen Breakdown of academic impact, for papers by Steven E. Carsons Breakdown of academic impact, for papers by Rachel H. McMahan Breakdown of academic impact, for papers by Omar Qureshi Breakdown of academic impact, for papers by Andrea Finocchi
Rankless by CCL
2026